Submission Details

Submitter:

Classification:
Limited
GENCC:100004
Gene:
Disease:
spermatogenic failure 27
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
03/09/2023
Evidence/Notes:

Spermatogenic failure-27 (SPGF27) is characterized by male infertility due to morphologic abnormalities of the flagella (MMAF), including flagella that are short, absent, irregularly shaped, and coiled. Ultrastructural analysis shows loss of the central pair of microtubules, loss of the inner dynein arms, and peripheral doublet disorganization (PMID: 29365104). The AK7 (Adenylate kinase 7) gene was first reported in association with Spermatogenic failure 27 (MONDO:0054731, OMIM: 617965) in 2018 (PMID: 29365104), and in PCD patients in 2012 (PMID: 22801010). Per criteria outlined by the ClinGen Lumping and Splitting Working Group and due to the differences in molecular mechanism and the phenotypic variability, the ClinGen Motile Ciliopathy GCEP working group estimated that Spermatogenic failure 27 (MONDO:0054731), and in PCD patients in 2012 (PMID: 22801010) represent distinct diseases and decided to split the entities. Evidence from two probands (PMID: 29365104 and PMID: 34854019) is included in this curation. Homozygous missense mutations were detected in both patients. Less than half a point (0.4) is reached with this genetic evidence. AK7 is phosphotransferase that catalyzes the interconversion of nucleoside phosphates. This reaction provides energy for cellular processes requiring a stable supply of ATP. The AK7 protein has a WcaG motif near the N terminus, followed by an AK domain and a C-terminal DPY30 motif. The WcaG motif is a signature of some prokaryotic nucleoside diphosphate sugar epimerases, and the DPY30 is a protein oligomerization motif.
This gene-disease association is supported by experimental evidence. Abundant data confirms the expression of AK7 in sperm flagella (PMID: 25613900, PMID: 29365104). Moreover, in patients with AK7 mutations, the expression of the protein in sperm was altered (PMID: 29365104 and PMID: 34854019). Ak7 knockout mice (Ak7 -/-) were generated by the insertion of a 4.5 kb transgene in the intron 5 of the AK7 gene (PMID: 18776131). No Ak7 expression was detected in homozygous transgenic mice. (Ak7 -/-) mice showed growth retardation, hydrocephalus, airway dilatation and thickening of airway walls, and excess of mucus in the paranasal sinuses. Male Ak7 -/- mice were infertile. They lacked mature spermatids and spermatozoa, and electron microscopy showed abnormal sperm heads and absence of tail structures (PMID: 18776131). Similar results were reported in (PMID: 21746835 and PMID: 29365104). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.This classification was approved by the ClinGen Motile Ciliopathy GCEP on March 9, 2023 (SOP Version 9).

PubMed IDs:
18776131 25613900 29365104 34854019
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.